1
|
Birkner S, Möhlendick B, Wilde B, Schoenfelder K, Boss K, Siffert W, Kribben A, Friebus-Kardash J. Single-Nucleotide Polymorphism in Genes Encoding G Protein Subunits GNB3 and GNAQ Increase the Risk of Cardiovascular Morbidity among Patients Undergoing Renal Replacement Therapy. Int J Mol Sci 2023; 24:15260. [PMID: 37894940 PMCID: PMC10607787 DOI: 10.3390/ijms242015260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/13/2023] [Revised: 10/09/2023] [Accepted: 10/13/2023] [Indexed: 10/29/2023] Open
Abstract
Single-nucleotide polymorphisms in G protein subunits are linked to an increased risk of cardiovascular events among the general population. We assessed the effects of GNB3 c.825C > T, GNAQ -695/-694GC > TT, and GNAS c.393C > T polymorphisms on the risk of cardiovascular events among 454 patients undergoing renal replacement therapy. The patients were followed up for a median of 4.5 years after the initiation of dialysis. Carriers of the TT/TT genotype of GNAQ required stenting because of coronary artery stenosis (p = 0.0009) and developed cardiovascular events involving more than one organ system (p = 0.03) significantly earlier and more frequently than did the GC/TT or GC/GC genotypes. Multivariate analysis found that the TT/TT genotype of GNAQ was an independent risk factor for coronary artery stenosis requiring stent (hazard ratio, 4.5; p = 0.001), cardiovascular events (hazard ratio, 1.93; p = 0.04) and cardiovascular events affecting multiple organs (hazard ratio, 4.9; p = 0.03). In the subgroup of male patients left ventricular dilatation with abnormally increased LVEDD values occurred significantly more frequently in TT genotypes of GNB3 than in CT/CC genotypes (p = 0.007). Our findings suggest that male dialysis patients carrying the TT genotype of GNB3 are at higher risk of left ventricular dilatation and that dialysis patients carrying the TT/TT genotype of GNAQ are prone to coronary artery stenosis and severe cardiovascular events.
Collapse
Affiliation(s)
- Simon Birkner
- Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany; (S.B.); (B.W.); (K.S.); (K.B.); (A.K.)
| | - Birte Möhlendick
- Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany (W.S.)
| | - Benjamin Wilde
- Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany; (S.B.); (B.W.); (K.S.); (K.B.); (A.K.)
| | - Kristina Schoenfelder
- Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany; (S.B.); (B.W.); (K.S.); (K.B.); (A.K.)
| | - Kristina Boss
- Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany; (S.B.); (B.W.); (K.S.); (K.B.); (A.K.)
| | - Winfried Siffert
- Institute of Pharmacogenetics, University Hospital Essen, University of Duisburg-Essen, 45147 Essen, Germany (W.S.)
| | - Andreas Kribben
- Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany; (S.B.); (B.W.); (K.S.); (K.B.); (A.K.)
| | - Justa Friebus-Kardash
- Department of Nephrology, University of Duisburg-Essen, University Hospital Essen, Hufelandstr. 55, 45147 Essen, Germany; (S.B.); (B.W.); (K.S.); (K.B.); (A.K.)
| |
Collapse
|
2
|
Pratamawati TM, Alwi I. Summary of Known Genetic and Epigenetic Modification Contributed to Hypertension. Int J Hypertens 2023; 2023:5872362. [PMID: 37201134 PMCID: PMC10188269 DOI: 10.1155/2023/5872362] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2022] [Revised: 04/07/2023] [Accepted: 04/13/2023] [Indexed: 05/20/2023] Open
Abstract
Hypertension is a multifactorial disease due to a complex interaction among genetic, epigenetic, and environmental factors. Characterized by raised blood pressure (BP), it is responsible for more than 7 million deaths per annum by acting as a leading preventable risk factor for cardiovascular disease. Reports suggest that genetic factors are estimated to be involved in approximately 30 to 50% of BP variation, and epigenetic marks are known to contribute to the initiation of the disease by influencing gene expression. Consequently, elucidating the genetic and epigenetic mediators associated with hypertension is essential for better discernment of its pathophysiology. By deciphering the unprecedented molecular hypertension basis, it could help to unravel an individual's inclination towards hypertension which eventually could result in an arrangement of potential strategies for prevention and therapy. In the present review, we discuss known genetic and epigenetic drivers that contributed to the hypertension development and summarize the novel variants that have currently been identified. The effect of these molecular alterations on endothelial function was also presented.
Collapse
Affiliation(s)
- Tiar Masykuroh Pratamawati
- Program Doctoral Biomedical Science, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia
- Department of Genetics, Faculty of Medicine, Universitas Swadaya Gunung Jati, Cirebon, Indonesia
| | - Idrus Alwi
- Division of Cardiology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Cipto Mangunkusumo National General Hospital, Jakarta, Indonesia
| |
Collapse
|
3
|
Li J, Bao J, Gao C, Wei Z, Tan L, Liu P, Wang Z, Tian S. Increased Serum E-Selectin Levels Were Associated with Cognitive Decline in Patients with Stroke. Int J Gen Med 2021; 14:733-739. [PMID: 33688244 PMCID: PMC7936714 DOI: 10.2147/ijgm.s292171] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2020] [Accepted: 01/22/2021] [Indexed: 01/01/2023] Open
Abstract
Background Previous studies have reported that patients with stroke have a high incidence of cognitive decline. The aim was to elucidate the association between serum E-selectin levels and cognitive function in stroke patients. Materials and Methods Serum levels of E-selectin were measured in 322 patients with stroke at baseline. Cox proportional hazard analysis was used to evaluate the predictive value of serum E-selectin for predicting cognitive decline (end point) in patients with stroke. Results Multivariate linear regression analysis revealed that serum E-selectin levels were independently associated with MOCA score after adjusting for age, gender, BMI, current smoker, current drinker, admission systolic and diastolic BP, CVD history and laboratory measurements in patients with stroke at baseline (Sβ= −0.156; 95% CI, - 0.170– - 0.074; P<0.001). The multivariate Cox proportional hazard analysis revealed that serum E-selectin (HR=2.481, 95% CI 1.533–4.327, P-trend <0.001) was an independent prognostic factor for cognitive decline in these patients with stroke during the follow-up period. Conclusion Our results showed that increased serum E-selectin levels were significantly and independently associated with cognitive decline and had independent predictive value for cognitive decline in patients with stroke. Serum E-selectin might enable early recognition of cognitive decline among stroke patients.
Collapse
Affiliation(s)
- Jin Li
- Department of Neurosurgery, The Affiliated Hospital of the Nco School, The Army Medical University, Shijiazhuang, 050041, Hebei, People's Republic of China
| | - Junqiang Bao
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050030, Hebei, People's Republic of China
| | - Chao Gao
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050030, Hebei, People's Republic of China
| | - Zibin Wei
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050030, Hebei, People's Republic of China
| | - Liguo Tan
- Department of Field Internal Medicine, The NCO School of The Army Medical University, Shijiazhuang, 050031 Hebei, China
| | - Ping Liu
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050030, Hebei, People's Republic of China
| | - Zhiwei Wang
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050030, Hebei, People's Republic of China
| | - Shujuan Tian
- Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, 050030, Hebei, People's Republic of China
| |
Collapse
|
4
|
Ferreira JP, Girerd N, Bozec E, Mercklé L, Pizard A, Bouali S, Eby E, Leroy C, Machu JL, Boivin JM, Lamiral Z, Rossignol P, Zannad F. Cohort Profile: Rationale and design of the fourth visit of the STANISLAS cohort: a familial longitudinal population-based cohort from the Nancy region of France. Int J Epidemiol 2019; 47:395-395j. [PMID: 29220499 DOI: 10.1093/ije/dyx240] [Citation(s) in RCA: 21] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 10/27/2017] [Indexed: 01/16/2023] Open
Affiliation(s)
- João Pedro Ferreira
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France.,Department of Physiology and Cardiothoracic Surgery, University of Porto, Porto, Portugal
| | - Nicolas Girerd
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Erwan Bozec
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Ludovic Mercklé
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Anne Pizard
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Sanae Bouali
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Elise Eby
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Céline Leroy
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Jean-Loup Machu
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Jean-Marc Boivin
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Zohra Lamiral
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Patrick Rossignol
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| | - Faiez Zannad
- Centre d'Investigations Cliniques Plurithématique, Université de Lorraine, Nancy, France
| |
Collapse
|